
We found that KRAS mutant tumors display lower expression of genes related to the tumor stroma and remodeling of the extracellular matrix. We profiled mRNA in 76 locally advanced rectal adenocarcinomas from patients that were enrolled in a prospective clinical trial and investigated differences in gene expression between KRAS mutant and KRAS wild type patients. We found that KRAS mt tumors display lower expression of genes related to the tumor stroma and remodeling of the extracellular matrix.
Like
Save
Share